Overview

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Status:
Completed
Trial end date:
2004-06-30
Target enrollment:
Participant gender:
Summary
A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Amlodipine
Atenolol
Hydrochlorothiazide
Losartan